Lilly’s Legal Division Steers Firm Through Rough Seas Of Civil, Patent Cases
Executive Summary
Set in a campus-like complex in downtown Indianapolis, Lilly projects a calm, unruffled atmosphere. A water fountain bubbles in front of the administrative building. Windows line the building's two-story lobby, filling the place with light. In front of the reception desk there is a display on the history of insulin, which Lilly first brought to market in 1923. And a museum with relics of the company's 133-year history stands behind it
You may also be interested in...
Lesson from Lilly’s Zyprexa Settlement: Be Proactive In Monitoring Sales Reps
Companies might shield themselves from claims of off-label drug marketing by adopting oversight procedures mandated in Lilly's corporate integrity agreement with HHS
Teva’s Generic Evista Launch Remains On Hold During Patent Trial
In second court-order delay, judge grants temporary restraining order, saying Lilly is likely to prevail in patent infringement trial.
BLA Exclusivity Would Ease Acquisitions And Improve R&D Focus, Lilly Says
Lilly has found another reason for follow-on biologics legislation to provide 14 years of data exclusivity for innovators: it will make the vetting process easier in mergers and acquisitions